Printer Friendly
The Free Library
14,508,411 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks Bull and Bear of the Day Highlights: Bayer A.G., Chemtura, Zumiez and Kookmin Bank.


CHICAGO -- Zacks Equity Research highlights Bayer A.G. (NYSE NYSE

See: New York Stock Exchange
:BAY) as the Bull of the Day and Chemtura Corporation Chemtura Corporation (NYSE: CEM) is a marketer of specialty chemicals, polymer products and processing equipment for a variety of industries. The company formed in 2005 from the merger of two other corporations -- Great Lakes Chemical Corporation of West Lafayette, Indiana,  (NYSE:CEM CEM

contagious equine metritis.


CEM selective medium
chocolate agar made with Eugon agar and 5% horse blood; used to cultivate Taylorella equigenitalis.
) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Zumiez (Nasdaq:ZUMZ) and Kookmin Bank Kookmin Bank (hangul:국민은행) is the largest bank by both asset value and market capitalization in South Korea.

The bank is led by Kang Chung-Won who previously worked for Seoulbank and oversaw its sale to competitor Hana Bank before moving to
 (NYSE:KB). Full analysis of all four stocks is available at http://at.zacks.com/?id=2676.

Here is a synopsis of all four stocks:

Bull of the Day:

Our Bull of the Day recommendation is for Bayer A.G. (NYSE:BAY). We expect Bayer to report a solid fourth quarter on March 15th, 2007. The growth in the third quarter was fueled by solid performance of the company's healthcare division, and we expect that to continue in the fourth quarter. BAY can finally start integrating Schering, which may hinder short-term profitability but should help fuel its long-term growth. The Materials Science materials science

Study of the properties of solid materials and how those properties are determined by the material's composition and structure, both macroscopic and microscopic.
 division continues to post solid growth, despite weakness in its margins caused by raw material costs. We continue to rate shares of BAY a Buy, and have raised our price target to $64.50 over the next six months.

Bear of the Day:

Our Bear of the Day recommendation is for Chemtura Corporation (NYSE:CEM). Chemtura was formed by the merger of Crompton Corporation Crompton Corporation, formerly Crompton and Knowles, is a chemical research, production, sales and distribution company headquartered in Middlebury, Connecticut. The company produces specialty chemicals used for polymers, fire suppressants and retardants, pool and spa water  and Great Lakes Chemical Corporation Great Lakes Chemical Corporation is a chemical research, production, sales and distribution company that produces specialty chemicals used for polymers, fire suppressants and retardants, pool and spa water purification systems and various other applications. . The merged entity faces integration risk. The company also is in the midst Adv. 1. in the midst - the middle or central part or point; "in the midst of the forest"; "could he walk out in the midst of his piece?"
midmost
 of a price/raw material squeeze. Additionally, aggressive pricing of some business has resulted in lost market share. The company also has huge unfunded pension obligations and a variable rate debt, which in turn reflects negatively on the company's financial strength. This leads us to rate the stock a Sell with a six-month target price of $10.50.

Analyst Blog:

Zumiez (Nasdaq:ZUMZ) reported fourth quarter sales of $111.5 million, up 49% year-over-year, with comp-store sales growth of 13%. These results were ahead of our estimates and show that Zumiez's holiday season was stronger than expected. We remain fans of Zumiez stores and the company's long-term growth potential. Still, ZUMZ shares are trading at 39.3 times our 2007 EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  [earnings per share] estimate, and we think the shares have gotten ahead of the company's fundamentals. We maintain our Hold rating and will continue to look for a better entry price before becoming more positive on the stock.

We recently reduced our recommendation on Kookmin Bank (NYSE:KB) to Hold from Buy as the shares exceeded our $85 target price. Our new target price is $90. KB reported fourth quarter earnings well below our estimate, primarily reflecting a government-mandated increase in loan loss provisions that caused provisions to surge 78% year over year. We are reducing our 2007 EPADS EPADS Earnings Per Average Diluted Share  [earnings per American Depositary Receipt American Depositary Receipt (ADR)

Certificates issued by a US depository bank, representing foreign shares held by the bank, usually by a branch or correspondent in the country of issue.
] estimate to $9.26 from $9.50. Improved asset quality and operating efficiency should drive earnings over the next couple of years. KB's agreement with Lone Star to buy Korea Exchange Bank Oehwan Bank or Korea Exchange Bank (KEB) (KSE: 004940) is South Korea's only exchange bank company. It is headquartered in Seoul, and was established in 1967.  ended in late November. While KB increased its payout ratio Payout Ratio

The percentage of earnings paid out in dividends. It is calculated by dividing dividends per share by earnings per share.

Notes:
The payout ratio indicates how well earnings support the dividend payments: the lower the ratio, the more secure the dividend.
 to 50% this year, resulting in a $3.85 dividend, it should revert to 30% in the future.

Get the full analysis of all four stocks by going to http://at.zacks.com/?id=2649.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis Qualitative Analysis

Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations.
 to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2677.

About Zacks

Zacks.com is a property of Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2650.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.

(b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs Transaction Costs

Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it).
, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 14, 2007
Words:1008
Previous Article:Zacks Analyst Blog Highlights: Linktone, China Mobile, Winston Hotels and Hilton Hotels.
Next Article:MacroArray Technologies Announces the Identification of a Urine Diagnostic Marker for High Grade PIN, a Precancerous Prostate Lesion.
Topics:



Related Articles
Zacks Bull and Bear of the Day Highlights: SAP A.G., Bank of the Ozarks, Grupo Aeroportuario del Sureste and CNH Global.
Zacks Bull and Bear of the Day Highlights: Sunoco, Neurocrine Biosciences, Bank of the Ozarks and Pepsi Bottling Group.
Zacks Analyst Interview Highlights: Credit Suisse Group, Kookmin Bank and UBS AG.
Zacks Bull and Bear of the Day Highlights: National Semiconductor, Del Monte Corporation, HDFC Bank and FactSet.
Zacks Bull and Bear of the Day Highlights: AtheroGenics, ProQuest Company, Bayer A.G. and Yahoo!
Zacks Bull and Bear of the Day Highlights: Regency Centers, Bank Mutual, Red Robin and Marchex.
Zacks Bull and Bear of the Day Highlights: United Retail Group, Bank Mutual, GATX and El Paso Corporation.
Zacks Bull and Bear of the Day Highlights: HDFC Bank, Sony Corp., Marlin Business Services and iPass, Inc.
Zacks Bull and Bear of the Day Highlights: Crocs, Inc., Auxilium Pharmaceuticals, Exxon Mobil and UBS AG.
Zacks Analyst Interview Highlights: National Australia Bank and Kookmin Bank.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles